Information Journal Paper
APA:
Copy. (2021). Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1. 1. 7): an exploratory analysis of a randomised controlled trial. LANCET, 397(10282), 1351-1362. SID. https://sid.ir/paper/1070026/en
Vancouver:
Copy. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1. 1. 7): an exploratory analysis of a randomised controlled trial. LANCET[Internet]. 2021;397(10282):1351-1362. Available from: https://sid.ir/paper/1070026/en
IEEE:
Copy, “Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1. 1. 7): an exploratory analysis of a randomised controlled trial,” LANCET, vol. 397, no. 10282, pp. 1351–1362, 2021, [Online]. Available: https://sid.ir/paper/1070026/en